No Causal Relation Between Bupropion in Therapeutic Dose and Serotonin Toxicity

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Murray B, Carpenter J, Dunkley C, Moran TP, Kiernan EA, Rianprakaisang T, et al. Toxicology Investigators Consortium (ToxIC). Single-agent bupropion exposures: clinical characteristics and an atypical cause of serotonin toxicity. J Med Toxicol. 2020; 16(1):12–16. https://doi.org/10.1007/s13181-019-00749-4.

  2. 2.

    Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ. 2014;348:g1626. https://doi.org/10.1136/bmj.g1626.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophan Res. 2019;12:1178646919873925. https://doi.org/10.1177/1178646919873925.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96(9):635–42.

    CAS  Article  Google Scholar 

  5. 5.

    Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Rev. 2006;12(3–4):178–207.

    Article  Google Scholar 

  6. 6.

    Gillman PK. Bupropion, bayesian logic and serotonin toxicity. J Med Toxicol. 2010;6(2):276–7. https://doi.org/10.1007/s13181-010-0084-8.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Moss MJ, Hendrickson RG. Toxicology Investigators Consortium (ToxIC). Serotonin toxicity: associated agents and clinical characteristics. J Clin Psychopharmacol. 2019;39(6):628–33. https://doi.org/10.1097/JCP.0000000000001121.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Wax PM, Kleinschmidt KC, Brent J, ACMT ToxIC Case Registry Investigators. The Toxicology Investigators Consortium (ToxIC) Registry. J Med Toxicol. 2011;7(4):259–65. https://doi.org/10.1007/s13181-011-0177-z.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Stewart E, Grewal K, Hudson H, Thompson M, Godwin J. Clinical characteristics and outcomes associated with bupropion overdose: a Canadian perspective. Clin Toxicol (Phila). 2019;12:1–6. https://doi.org/10.1080/15563650.2019.1699658.

    CAS  Article  Google Scholar 

  10. 10.

    Agency for Healthcare Research and Quality (AHRQ). Prescription data source: Medical Expenditure Panel Survey (MEPS) 2007–2017. ClinCalc DrugStats Database version 20.0. https://clincalc.com/DrugStats/Drugs/Bupropion, assessed 3 Jan 2020.

  11. 11.

    Nanji KC, Seger DL, Slight SP, Amato MG, Beeler PE, Her QL, et al. Medication-related clinical decision support alert overrides in inpatients. J Am Med Inform Assoc. 2018;25(5):476–81. https://doi.org/10.1093/jamia/ocx115.

    Article  PubMed  Google Scholar 

  12. 12.

    Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351(4):387–99. https://doi.org/10.1016/j.amjms.2016.01.010.

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sander D. Borgsteede.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supervising Editor: Lewis Nelson, MD

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Borgsteede, S.D., Birkenhager, T.K., Zaal, R.J. et al. No Causal Relation Between Bupropion in Therapeutic Dose and Serotonin Toxicity. J. Med. Toxicol. 16, 333–334 (2020). https://doi.org/10.1007/s13181-020-00761-z

Download citation